PROSPECT GIARDIA/CRYPTOSPORIDIUM MICROPLATE ASSAY— 510(k) K955157

Substantially Equivalent

Alexon Biomedical, Inc.

FDA 510(k) clearance K955157 for PROSPECT GIARDIA/CRYPTOSPORIDIUM MICROPLATE ASSAY, Substantially Equivalent on 1996-02-09. Applicant: Alexon Biomedical, Inc..

Clearance details

Applicant
Alexon Biomedical, Inc.
Product code
Code MHI
Advisory panel
Microbiology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Sunnyvale, CA, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.